Fluorouracil (Fluorouracil) Patent Expiration, LOE Window & CMS Spending

Fluorouracil (Fluorouracil) by Spectrum: Off-Patent Genericized (AB Competition), 4 AB generics, $56.3M 2024 CMS Part D & Medicaid spend, and $1,421 CA SB 17 specialty launch WAC.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorSpectrum
FDA Application & PathwayN012209 (NDA)
Exclusivity / Cliff HorizonOff-Patent Genericized (AB Competition)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity DateNot listed / N/A
Orange Book Patents (*PED Extensions)0 patents (0 *PED)
Active AB-Rated Generic Competitors4
2024 CMS Total Public Spend$56.3M
2024 Medicare Part D Spend$45.6M
2024 Medicaid Spend$10.7M
Reported Wholesale Price Change (CA SB 17)Specialty launch notice ($1,421 intro WAC)